Furiex Pharmaceuticals Company Profile

14:13 EDT 25th October 2014 | BioPortfolio


News Articles [19 Associated News Articles listed on BioPortfolio]

Actavis Acquires Furiex Pharmaceuticals

Actavis plc announced that its subsidiary Forest Laboratories LLC has successfully completed its acquisition of Furiex Pharmaceuticals Inc.Read more

Actavis Closes Acquisition Of Furiex Pharma

WASHINGTON (dpa-AFX) - Actavis plc (ACT) announced that its subsidiary Forest Laboratories, LLC has completed its acquisition of Furiex Pharmaceuticals Inc. (FURX) in an all-cash transaction value...

UPDATE 1-Forest Labs wins U.S. antitrust approval to buy Furiex

WASHINGTON, May 30 (Reuters) - Forest Laboratories Inc , which itself is in the process of being acquired, has won U.S. antitrust approval to buy Furiex Pharmaceuticals Inc , the Federal Trade Commiss...

Furiex Pharma Slips To Loss Amid Revenue Slump, Misses Estimate

WASHINGTON (dpa-AFX) - Furiex Pharmaceuticals Inc (FURX) Wednesday reported first-quarter net loss of $13 million or $1.25 per share compared with a profit of $9 million or $0.82 per share last ye...

Forest Labs wins U.S. antitrust approval to buy Furiex

WASHINGTON, May 30 (Reuters) - Forest Laboratories Inc has won U.S. antitrust approval to buy Furiex Pharmaceuticals Inc, the Federal Trade Commission said on Friday.

Earnings Results, Acquisitions, Drug Designations, Dividend Authorizations, and Licensing Agreements - Analyst Notes on AstraZeneca, Furiex, GW, Techne and Agenus

NEW YORK, May 5, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding AstraZeneca PLC (NYSE: AZN), Furiex Pharmaceuticals, Inc. (NASDAQ: FURX), GW Pharmaceuticals plc...

Forest Laboratories completes acquisition of Furiex Pharmaceuticals

Actavis plc today announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex Pharmaceuticals, Inc. in an all-cash transaction valued at approximately $...

Approvals, Agreements, Name Change, and Partnerships - Analyst Notes on Johnson & Johnson, Furiex Pharmaceuticals, Select Medical, CTI and Hill-Rom

NEW YORK, June 13, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Johnson & Johnson (NYSE: JNJ), Furiex Pharmaceuticals, Inc. (NASDAQ: FURX), Select Medical Hol...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Furiex Pharmaceuticals, Inc.

Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by adva...

Furiex Pharmaceuticals

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

More Information about "Furiex Pharmaceuticals" on BioPortfolio

We have published hundreds of Furiex Pharmaceuticals news stories on BioPortfolio along with dozens of Furiex Pharmaceuticals Clinical Trials and PubMed Articles about Furiex Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Furiex Pharmaceuticals Companies in our database. You can also find out about relevant Furiex Pharmaceuticals Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record